Found 2 hits Enz. Inhib. hit(s) with Target = 'Nociceptin receptor' and Ligand = 'BDBM50106476' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM50106476
(CHEMBL435511 | FGGFTGCRKSCRK)Show SMILES C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(N)=O Show InChI InChI=1S/C61H98N22O15S2/c1-34(85)49(83-55(94)42(27-36-16-6-3-7-17-36)75-47(87)29-72-46(86)28-73-51(90)37(64)26-35-14-4-2-5-15-35)59(98)74-30-48(88)76-44-32-99-100-33-45(58(97)80-40(20-12-24-70-60(66)67)52(91)77-38(50(65)89)18-8-10-22-62)82-56(95)43(31-84)81-54(93)39(19-9-11-23-63)78-53(92)41(79-57(44)96)21-13-25-71-61(68)69/h2-7,14-17,34,37-45,49,84-85H,8-13,18-33,62-64H2,1H3,(H2,65,89)(H,72,86)(H,73,90)(H,74,98)(H,75,87)(H,76,88)(H,77,91)(H,78,92)(H,79,96)(H,80,97)(H,81,93)(H,82,95)(H,83,94)(H4,66,67,70)(H4,68,69,71)/t34-,37+,38+,39+,40+,41+,42+,43+,44+,45+,49+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.04 | n/a | n/a | n/a | n/a | n/a | n/a |
Tohoku Pharmaceutical University
Curated by ChEMBL
| Assay Description Displacement of [3H]-NC from human ORL1 receptor expressing HEK-293 cell membrane |
J Med Chem 44: 4015-8 (2001)
BindingDB Entry DOI: 10.7270/Q25H7FJJ |
More data for this Ligand-Target Pair | |
Nociceptin receptor
(Homo sapiens (Human)) | BDBM50106476
(CHEMBL435511 | FGGFTGCRKSCRK)Show SMILES C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(N)=O Show InChI InChI=1S/C61H98N22O15S2/c1-34(85)49(83-55(94)42(27-36-16-6-3-7-17-36)75-47(87)29-72-46(86)28-73-51(90)37(64)26-35-14-4-2-5-15-35)59(98)74-30-48(88)76-44-32-99-100-33-45(58(97)80-40(20-12-24-70-60(66)67)52(91)77-38(50(65)89)18-8-10-22-62)82-56(95)43(31-84)81-54(93)39(19-9-11-23-63)78-53(92)41(79-57(44)96)21-13-25-71-61(68)69/h2-7,14-17,34,37-45,49,84-85H,8-13,18-33,62-64H2,1H3,(H2,65,89)(H,72,86)(H,73,90)(H,74,98)(H,75,87)(H,76,88)(H,77,91)(H,78,92)(H,79,96)(H,80,97)(H,81,93)(H,82,95)(H,83,94)(H4,66,67,70)(H4,68,69,71)/t34-,37+,38+,39+,40+,41+,42+,43+,44+,45+,49+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | n/a | n/a | 156 | n/a | n/a | n/a | n/a |
Tohoku Pharmaceutical University
Curated by ChEMBL
| Assay Description Efficacy for human ORL1 receptor expressing HEK-293 cells |
J Med Chem 44: 4015-8 (2001)
BindingDB Entry DOI: 10.7270/Q25H7FJJ |
More data for this Ligand-Target Pair | |